CRC role boundary violations frequently correlate with investigators' insufficient awareness of regulatory requirements and clinical trial protocols. As principal contributors to clinical research, investigators must clearly delineate and fulfill their essential trial-related obligations. Concurrently, CRCs should strictly adhere to Good Clinical Practice (GCP) guidelines and industry standards while assisting investigators, thereby collectively enhancing trial efficiency and quality.
Shi et al. (Tue,) studied this question.